The DOI matches its Crossref record; 316 of the 316 references it cites were found in a registry or an index.
The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
Open accessAbstract
Tumorigenesis is a highly complex process, involving many interrelated and cross-acting signalling pathways. One such pathway that has garnered much attention in the field of cancer research over the last decade is the Hippo signalling pathway. Consisting of two antagonistic modules, the pathway plays an integral role in both tumour suppressive and oncogenic processes, generally via regulation of a diverse set of genes involved in a range of biological functions. This review discusses the history of the pathway within the context of cancer and explores some of the most recent discoveries as to how this critical transducer of cellular signalling can influence cancer progression. A special focus is on the various recent efforts to therapeutically target the key effectors of the pathway in both preclinical and clinical settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
G PROTEINS: TRANSDUCERS OF RECEPTOR-GENERATED SIGNALS
Gilman, A. G. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.003151 · Cited by 6,381
Role of YAP/TAZ in mechanotransduction
Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979
Selective inhibition of BET bromodomains
Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262
Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
Whyte, W. A., Orlando, D. A., Hnisz, D., Abraham, B. J., Lin, C. Y., Kagey, M. H., Rahl, P. B., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.035 · Cited by 4,143
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
Genomic analyses identify molecular subtypes of pancreatic cancer
Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A.-M., Gingras, M.-C., Miller, D. K., Christ, A. N., Bruxner, T. J. C., Quinn, M. C., et al. (2016) · Nature · doi:10.1038/nature16965 · Cited by 3,621
On Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
Ishida, Y., Agata, Y., Shibahara, K., & Honjo, T. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05481.x · Cited by 3,256
Liquid-Liquid Phase Separation in Biology
Hyman, A. A., Weber, C. A., & Jülicher, F. (2014) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100913-013325 · Cited by 3,155
Research works printed but not linked: 12
- Evans, 2009, Neurofibromatosis 2 [Bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II], Genet. Med., 11, 599, 10.1097/GIM.0b013e3181ac9a27 · doi:10.1097/gim.0b013e3181ac9a27
- Begnami, 2007, Evaluation of NF2 gene deletion in sporadic schwannomas, meningiomas, and ependymomas by chromogenic in situ hybridization, Hum. Pathol., 38, 1345, 10.1016/j.humpath.2007.01.027 · doi:10.1016/j.humpath.2007.01.027
- Yakirevich, 2020, NF2 mutation-driven renal cell carcinomas (RCC): a comprehensive genomic profiling (CGP) study, J. Clin. Oncol., 38, 726, 10.1200/JCO.2020.38.6_suppl.726 · doi:10.1200/jco.2020.38.6_suppl.726
- Zhao, 2007, Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control, Genes Dev., 21, 2747, 10.1101/gad.1602907 · DOI · Paper page
- Lee, 2016, Epithelioid hemangioendotheliomas with TFE3 gene translocations are compossible with CAMTA1 gene rearrangements, Oncotarget, 7, 7480, 10.18632/oncotarget.7060 · doi:10.18632/oncotarget.7060
- Russell-Goldman, 2021, Utility of YAP1 and NUT immunohistochemistry in the diagnosis of porocarcinoma, J. Cutan. Pathol., 48, 403, 10.1111/cup.13924 · doi:10.1111/cup.13924
- Nishimura, 2021, Cutaneous primary NUT carcinoma with BRD3-NUTM1 fusion, Am. J. Surg. Pathol., 45, 1582, 10.1097/PAS.0000000000001801 · doi:10.1097/pas.0000000000001801
- Pei, 2015, YAP is a critical oncogene in human cholangiocarcinoma, Oncotarget, 6, 17206, 10.18632/oncotarget.4043 · DOI
- Carter, 1994, Loss of heterozygosity at 11q22-q23 in breast cancer, Cancer Res., 54, 6270
- Messmer, 2001, Verteporfin for age-related macular degeneration, Ann. Pharmacother., 35, 1593, 10.1345/aph.10365 · doi:10.1345/aph.10365 · Paper page
- Taniguchi, 2015, A gp130-Src-YAP module links inflammation to epithelial regeneration, Nature, 519, 57, 10.1038/nature14228 · DOI · Paper page
- Whitehouse, 2005, Drugs to treat inflammation: a historical introduction, Curr. Med. Chem., 12, 2931, 10.2174/092986705774462879 · doi:10.2174/092986705774462879
Cited by
Insights into recent findings and clinical application of YAP and TAZ in cancer
Franklin, J. M., Wu, Z., & Guan, K.-L. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-023-00579-1 · Cited by 213
Therapeutic targeting of TEAD transcription factors in cancer
Pobbati, A. V., Kumar, R., Rubin, B. P., & Hong, W. (2023) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2022.12.005 · Cited by 147
Metadata
- Authors
- Cunningham, R., & Hansen, C. G.
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2022-02
- Volume
- 136
- Issue
- 3
- Pages
- 197-222
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W4210383344
- Cited by
- 326
- References
- 316
- FWCI
- 29.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer. https://app.cochat.ai/papers/10.1042/cs20201474
- The paper
- Cunningham, R., & Hansen, C. G. (2022). The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer. Clinical Science. https://doi.org/10.1042/cs20201474
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.